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Abstract
Very small embryonic-like (VSEL) cells have been described as putatively pluripotent stem cells present in murine bone
marrow and human umbilical cord blood (hUCB) and as such are of high potential interest for regenerative medicine.
However, there remain some questions concerning the precise identity and properties of VSEL cells, particularly those
derived from hUCB. For this reason, we have carried out an extensive characterisation of purified populations of VSEL cells
from a large number of UCB samples. Consistent with a previous report, we find that VSEL cells are CXCR4
+, have a high
density, are indeed significantly smaller than HSC and have an extremely high nuclear/cytoplasmic ratio. Their nucleoplasm
is unstructured and stains strongly with Hoechst 33342. A comprehensive FACS screen for surface markers characteristic of
embryonic, mesenchymal, neuronal or hematopoietic stem cells revealed negligible expression on VSEL cells. These cells
failed to expand in vitro under a wide range of culture conditions known to support embryonic or adult stem cell types and
a microarray analysis revealed the transcriptional profile of VSEL cells to be clearly distinct both from well-defined
populations of pluripotent and adult stem cells and from the mature hematopoietic lineages. Finally, we detected an
aneuploid karyotype in the majority of purified VSEL cells by fluorescence in situ hybridisation. These data support neither
an embryonic nor an adult stem cell like phenotype, suggesting rather that hUCB VSEL cells are an aberrant and inactive
population that is not comparable to murine VSEL cells.
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Introduction
Over the last ten years, there have been various reports of the
isolation of putatively pluripotent cells from bone marrow,
umbilical cord blood and other tissues [1–4]. However, many of
these findings still await independent confirmation and there is
increasing scepticism towards the existence of pluripotent stem
cells in the adult [5–7]. Since the majority of the isolation
procedures involve the in vitro culture of primary cells, there is
always the possibility that culture variables make a decisive
contribution to the emergence of pluripotency and that these have
not been reproduced exactly between different laboratories.
The discovery of very small embryonic-like (VSEL) stem cells in
adult bone marrow and umbilical cord blood promised to shed
light on this controversy, since here for the first time was a highly
versatile and putatively pluripotent cell type that could be isolated
directly from primary tissue and investigated without the need for
intervening culture [8,9]. Murine VSEL cells have been described
as a rare population of small cells which over express pluripotency
genes including Oct4, Nanog and SOX2 at both the mRNA and
protein levels, and maintain a demethylated Oct4 promotor. They
have euchromatic nuclei and are reportedly able to adopt the
phenotype of tissues from all three germ layers upon differentiation
in vitro. However, unlike pluripotent ES, EC or iPS cells, murine
bone marrow derived VSEL cells do not form teratomas in vivo
[9,10]. Furthermore no contribution of these cells to chimeric
embryos has been demonstrated, so that evidence for classical
pluripotency is still lacking. Thus, although it has been suggested
that VSEL cells could play a role in regeneration and tissue repair,
both their true physiological function and their origin remain
uncertain.
Even less information is available concerning human VSEL
cells, possibly because of reported difficulties with their isolation.
They were initially described as a rare population of small cells
within the non-hematopoietic CD45
2Lin
2 UCB population
which should also contain the endothelial and mesenchymal
progenitors frequently isolated from UCB [11–14]. In common
with their murine counterparts, VSEL cells from hUCB
reportedly have a high nucleus to cytoplasm ratio, euchromatic
chromatin, and a high expression of pluripotency genes at mRNA
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quently been reported to express the surface markers CXCR4,
CD34 and CD133 characteristic of adult stem and progenitor
populations, as well as the SSEA-4 antigen found on embryonic
stem cells.
However, the representation of these markers and the
relationship between them on the CD45
2Lin
2 population has
not been investigated systematically so that the precise phenotype
of human VSEL cells in this respect remains unclear. As an
example, the initial description of human UCB-derived VSEL
cells presented detailed immunophenotypic and electron micro-
scopic analysis of CD45
2Lin
2CXCR4
+ VSEL cells, while a later
publication of the same group reports an isolation protocol based
on magnetic enrichment of CD133
+ cells, irrespective of any
CXCR4 expression [8,15]. As far as we are aware, these
populations have not yet been characterized or compared
functionally. In order to clarify the features of the hVSEL cells
in more detail, we have established a comprehensive phenotypic
profile of the Lin-CD45- population and optimised an isolation
protocol for the Lin-CD45-CXCR4+ VSEL cells. Furthermore,
we have carried out a transcriptional and karyotypic analysis of
UCB derived VSEL cells. A carefully controlled cytometric
analysis showed the CXCR4+ VSEL cells to comprise the largest
part of the CD45
2Lin
2 population in hUCB, but to essentially
lack the previously ascribed stem cell markers CD34, CD133 or
SSEA-4. The purified human VSEL cells respond to none of a
range of culture conditions known to support other stem cell
populations, with the exception of a very low frequency of
hematopoietic activity most probably resulting from low-level
carryover of CD34
+CD45
dim cells. Furthermore, microarray
transcription analysis revealed VSEL cells to be clearly distinct
both from adult and embryonic stem cell populations and from
mature hematopoietic lineages. Last but not least, we found
hVSEL cells to display a high degree of aneuploidy. These data
support neither a classical adult nor embryonic stem cell like
phenotype for hVSEL cells.
Materials and Methods
Unless stated otherwise, all chemicals were purchased from
Sigma-Aldrich, Taufkirchen, Germany.
Preparation of primary human umbilical cord blood cells
Human UCB was obtained from healthy full-term pregnancies
with informed written consent of the parents according to
guidelines approved by the ethics committee of the Universita ¨t
Leipzig and according to the manufacturing authorisation for
UCB transplants of Vita34 AG. Fresh cord blood was analyzed
within 48 hours after birth. Total nucleated cells (TNC) were
prepared by ammonium chloride lysis (lysis buffer: 150 mM
NH4Cl, 10 mM NaHCO3, 0,1 mM EDTA; 1–2610 min, room
temperature (RT)). Light-density mononuclear cells (MNC) were
isolated from the interphase after Ficoll density gradient
centrifugation (35 min; 300 g; Ficoll 1.077 kg/L, Biochrom,
Berlin, Germany) and also subjected to ammonium chloride lysis.
High-density nucleated cells, which separated together with
erythrocytes in the pellet under the Ficoll gradient, were also
recovered by ammonium chloride lysis. After lysis, all cells were
washed with PBS with 0.5% human serum albumin (HSA, PAA,
Pasching, Austria) and 0.6% citrate phosphate dextrose (CPD).
This buffer was also used for subsequent antibody labelling, FACS
analysis, and cell sorting.
FACS analysis
Multiparameter FACS analysis was conduced on an LSR II
flow cytometer with DIVA 6.1.3 software (Becton Dickinson,
Heidelberg, Germany). FlowJo 9 software (Tree Star Inc.,
Ashland, USA) was used for data evaluation. Monoclonal
antibodies were purchased from Becton Dickinson, Heidelberg,
Germany (SSEA-1-phycoerythrin (PE), (MC480); SSEA-3-PE
(MC631); SSEA-4-PE (MC813-70); Tra-1-81-Alexa 647 (Tra-1-
81); CD140a-PE (aR1); CD184-PE (12G5); CD235a-PE-Cy5
(HIR2)); Biolegend, Fell, Germany (CD31-Alexa 488 (WM59);
CD34-PE-Cy7 (581); CD48-PE (BJ40); CD324-allophycocyanin
(APC), (67A4); eBioscience, Frankfurt, Germany (CD38-APC
(HIT2); CD45-Biotin and CD45-APC-eFlour 780 (HI30); CD84-
Biotin (2G7); CD90-PE-Cy5 (5E10); CD105-Alexa 488 (43A3);
CD144-APC (16B1); CD243-PE (UIC2); CD244-PE (C1.7));
Miltenyi Biotec, Bergisch Gladbach, Germany (anti-biotin-fluo-
rescein isothiocyanate (FITC), (Bio3-18E7); FcR-Blocking Reagent
human (#130-059-901); Lineage Cell Depletion Kit (#130-092-
211) incl. CD2, CD3, CD11b, CD14, CD15, CD16, CD19,
CD56, CD123 and CD235a; MSCA-1-Biotin (W8B2); PSA-
NCAM-PE (2-2B); CD133-APC (293C3); CD271-APC (ME20.4-
1.H4)); and R&D Systems, Wiesbaden-Nordenstadt, Germany
(CD338-PE (3D5)). All antibody stainings were conducted for 20–
30 min at RT in the presence of FCR-Blocking Reagent. The cell
permeable DNA dye Hoechst 33342 (HO) was included at 10 mg/
mL during the antibody staining to allow the discrimination of
nucleated cells (HO
+) from cell debris (HO
2). 2 mg/mL propidium
iodide (PI) was added to the FACS tube before analysis to allow
the exclusion of PI
+ dead cells.
Cell sorting
Lineage negative (Lin
2) cells were prepared from TNC using
the Lineage Cell Depletion Kit with LS columns according to the
manufacturer’s instructions (Miltenyi Biotec, Bergisch Gladbach,
Germany). Lin
2 cells were first labelled with anti-CD45-biotin,
followed by a secondary staining with anti-biotin-FITC, anti-
CXCR4-PE and anti-CD34-PE-Cy7. Stainings were conducted at
RT for 20–30 min. Before FACS sorting, PI was added at 2 mg/
mL to allow the exclusion of dead cells. In a first round of FACS
sorting, Lin
2CD45
dimCD34
+ cells, and Lin
2CD45
2 cells were
enriched. A second sort of the separated populations was
conducted to further purify CD34
+CD45
dim cells and
Lin
2CD45
2CXCR4
+ VSEL cells, respectively. For microarray
analysis, Lin
2CD45
2CXCR4
+CD34
2 (CD34
2VSEL cells) and
Lin
2CD45
2CXCR4
+CD34
+ (CD34
+VSEL cells) were separated
during the second sort.
Cytometry and cell staining
Cytospins from sorted CD34
+CD45
dim cells or VSEL cells were
air dried, fixed with methanol and stained with May-Gru ¨nwald
(5 min) and Giemsa (1:20, 20 min). Cytospin preparation leads to
flattening of larger cells. Hence, the size of CD34
+CD45
dim cells
and VSEL cells was determined from sorted cells that were
allowed to sediment onto poly-L-lysin coated slides. The area and
diameter of CD34
+CD45
dim cells and VSEL cells immobilised that
way was measured manually using NIS-Elements Br Software
Package (Nikon, Du ¨sseldorf, Germany).
Karyotyping of cytospin preparations was done with site specific
fluorescent in situ hybridisation (FISH) probes from Metasystems
(Altlussheim, Germany) according to the instruction of the
manufacturer. The dual-colour kit XL P53/DLEU detects the
long arm of chromosome 13 and in the short arm of chromosome
17. A Texas Red labelled probe detects a specific region at 13q14
including the DLEU1 and DLEU2 genes and marker D13S319.
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at 17p13. The dual-colour centromeric probe kit XCE 7/8 was
used to identify chromosomes 7 and 8. The probe for chromosome
7 was labelled with Texas Red, the probe for chromosome 8 with
FITC.
Cell culture
Basic cell culture media, human serum albumin (HSA), trypsin,
accutase, L-glutamine, and leukemia inhibitory factor (LIF) were
purchased from PAA (Pasching, Austria). Human recombinant
cytokines (stem cell factor (SCF), thrombopoietin (TPO), Fms-
related tyrosine kinase 3 ligand (FL), epidermal growth factor
(EGF), fibroblast growth factor-basic (FGF), tumour growth factor-
beta (TGF-b)) were purchased from Peprotech (Hamburg,
Germany). CHIR99021 (GSK-3b inhibitor) was purchased from
Sigma-Aldrich (Taufkirchen, Germany). Commercial media for
human hematopoietic stem cells (Methocult, Stem Cell Technol-
ogies, Ko ¨ln, Germany), human pluripotent stem cells (Nutristem,
Stemgent/Miltenyi, Bergisch Gladbach, Germany; TeSR1, Stem
Cell Technologies, Ko ¨ln, Germany), murine pluripotent stem cells
(ESGRO, Millipore, Schwalbach, Germany) and mesenchymal
stem cells (Stempro MSC SFM, Invitrogen, Karlsruhe, Germany;
MesenchymStem Medium, PAA, Pasching, Austria) were used
according to the instruction of the manufacturer. Cultures with
media for pluripotent stem cells were set up in culture plates
coated with Matrigel (BD, Heidelberg, Germany). OP9 stroma
cells were cultured in Iscove’s modified dulbecco’s medium
(IMDM) with 20% fetal calf serum (FCS), 2 mM L-glutamine.
Mouse embryonic fibroblasts (MEF) were cultured in Dulbecco’s
modified eagle medium (DMEM) low glucose with 1% non-
essential amino acids and 10% FCS. Freshly sorted VSEL cells
were cultured in various cell culture media including all
commercial media and self-made media supplemented with
combinations of SCF, FL and TPO; EGF and FGF; LIF; and
FGF and TGF-b each with and without CHIR99021. VSEL cells
were also seeded onto OP9 or irradiated MEF stroma cells.
Microarray analysis
Sorted CD34
2 and CD34
+VSEL cells from three individual
cord blood units were lysed in RLT buffer (Qiagen, Hilden,
Germany) and stored at 280uC. RNA extraction, labelling,
hybridisation and microarray analysis was conducted by AROS
Applied Biotechnology AS (Aarhus, Denmark) using Rneasy kit
(Qiagen, Hilden, Germany), NuGen Pico labelling kit (NuGen,
San Carlos, USA) and Affymetrix GeneTitan Human Genome
U219 microarray (Affymetrix, Santa Clara, USA) according to in-
house protocols. Microarray data quality was checked with
arrayQualityMetrics [16].
Our transcription data were compared with .200 raw datasets
from the gene expression omnibus (GEO) database using R,
bioconductor and MultiExperiment Viewer (MeV) according to
the following algorithm [17,18]. Briefly, [I] raw data were loaded
into R, [II] probe sets for each platform were annotated, [III]
genes, proteins or transcripts common to all platforms were
matched, including checks for redundancy or missing values, [IV]
data were compiled into a new ‘‘virtual array’’, [V] normalized
and [VI] subjected to batch effect removal using ComBat.R with
MAQC (microarray quality control) data sets as an internal
control for every platform [19]. The algorithm has been
implemented into a new bioconductor package called virtualArray
(http://www.bioconductor.org/packages/2.10/bioc/html/
virtualArray.html).
The ‘‘virtual array’’ thus generated was exported and analyzed
in MeV. Transcriptome wide principal component analysis (PCA)
and hierarchical clustering (HCL) were performed to illustrate
similarities and differences between VSEL cells and embryonic
and adult stem cells, as well as mature blood cell types [20,21]. An
un-rooted cluster tree was generated with Archaeopteryx [22].
Furthermore, a more focused comparison of a potential pluripo-
tency signature in VSEL cells was conducted using a subset of
pluripotency associated genes queried from www.genecards.org
(search term: pluripotency; category: protein-coding) [23]. 371 of
413 queried genes were retrieved in the virtual array and used for
further evaluation (Table S1). Expression levels in selected cell
populations were tested for significance by Mann-Whitney test
(critical p-value=0.01).
Statistics and graphs
Statistical analysis and box-plots were performed with Analyse-
it (Analyse-it Ltd., Leeds, United Kingdom). Skeletal box-plots
show median, 1
st and 3
rd quartile, maximum and minimum.
Student’s t-test and the Mann-Whitney test and were used to test
significance where appropriate.
Results
The immunophenotype of CD45
2Lin
2 hUCB cells
Human umbilical cord blood derived VSEL cells have been
described to be CD45
2Lin
2 and to carry one or more of the cell
surface markers CXCR4, CD133, CD34 and SSEA-4. However,
none of these markers is unique for VSEL cells, as they are also
expressed on hematopoietic stem and progenitor cells (CD34,
CD133), leucocytes (CXCR4) or erythroid cells (SSEA-4). Aiming
to define the VSEL cell phenotype more thoroughly, we selected a
number of established markers for embryonic, mesenchymal,
hematopoietic and neuronal stem cells, and analysed their
abundance and distribution on the population of living nucleated
CD45
2Lin
2 cells, of which the VSEL population is a part. The
exclusion of dead cells and cell debris by PI and Hoechst 33342
staining, the reduction of false positive events by FcR-blocking
reagent, and the exclusion of doublets by pulse processing the
FACS signals proved vital to the clear discrimination and gating of
CD45
2Lin
2 cells in UCB preparations after NH4Cl lysis
(Figure 1).
From a total of 22 markers tested, only three were found
positive: CD31, CD84 and the previously described VSEL cell
marker CXCR4 (Figure 2, Table 1). All of these markers were
.90% positive on the CD45
2Lin
2 population. In addition to
confirming that the cells identified here are equivalent to those
originally described as VSEL by Kucia et al. [8], this shows that
the CD45
2Lin
2 population is essentially identical to the
previously described CD45
2Lin
2CXCR4
+ VSEL cell population,
provided cell debris, dead cells and doublets are identified and
gated-out during data analysis.
CD31 and CD84 emerge from this analysis as two newly
identified positive markers on VSEL cells. However, CXCR4,
CD31 and CD84 are all also present on various types of mature
blood cells and therefore cannot be used alone or in combination
for stringent positive enrichment of VSEL cells. Somewhat
surprisingly, very few CD133 or CD34 were detected on the
CD45
2Lin
2 population even when up to 2*10
6 TNC were
analysed (Figure 2 B).
Loss of VSEL cells during ficoll gradient centrifugation
It has been previously reported that ficoll density gradient
centrifugation commonly used to recover mononuclear cells
(MNC) and CD34
+CD45
dim cells from UCB leads to loss of
VSEL cells [8,15,24]. To investigate this phenomenon in more
hUCB VSEL Cells Lack Stem Cell Characteristics
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recovered from the pellet after density gradient centrifugation, we
have studied the distribution of VSEL cells and CD34
+CD45
dim
cells between the interphase and the pellet using standard ficoll
(1.077 kg/L) density gradients. After separation and subsequent
ammonium chloride lysis, we were able to recover roughly equal
amounts of TNC from the interphase (predominantly mononu-
clear cells) and pellet (predominantly erythrocytes and polymor-
pholeukocytes) (Figure 3 A). As expected, CD34
+CD45
dim cells
were predominantly enriched in the interphase. In contrast, VSEL
cells were more abundant in the pellet, indicating that the density
of most VSEL cells is higher than that of CD34
+CD45
dim cells and
mononuclear cells (Figure 3 B, C). Thus, while VSEL cells are
insensitive to NH4Cl lysis, we confirm that ficoll density gradient
centrifugation does indeed lead to considerable loss of ,60% (10–
95%; n=15) of the VSEL cells. Since we did not detect any
phenotypic differences between VSEL cells from the interphase or
the pellet during subsequent FACS analysis, we chose to pre-
enrich by NH4Cl lysis rather than density gradient separation in
subsequent experiments in order to retain the entire VSEL
population.
Isolation and purification of VSEL cells
In an average hUCB less than 1 in 5000 TNC is a
CD45
2Lin
2CXCR4
+ VSEL cell. Since direct sorting of such
low frequency cells is associated with increased sort times and a
decrease in yield and purity, we chose a strategy of MACS based
lineage depletion followed by double FACS sorting for high purity.
In this way, we were able to successfully isolate a population of
CD45
2Lin
2CXCR4
+ cells from every hUCB tested. In order to
better distinguish the CD45
2 VSEL cells from the CD45
dim cells
in FACS plots, we also stained for CD34, which the analyses
shown above show to be highly expressed on CD45
dim cells but
very rare on VSEL cells. At the higher level of resolution possible
after removing Lin
+ TNC, we did detect a very low level of
CD34
+VSEL cells in some UCB samples (Figure 4). Although
these account for a relatively small fraction of the VSEL
population, we selected three hUCB samples with prominent
CD34
+VSEL cells and separated CD34
+ and CD34
2 VSEL cells
for the individual transcriptional profiling described below. In all
other experiments, we pooled the CD34
+VSEL cells into the much
larger CD45
2Lin
2CXCR4
+CD34
2 population. The averaged
frequency of CD34
+CD45
dim cells, CD34
2VSEL and
CD34
+VSEL cells in lineage negative UCB cells was 33%+/
214%, 22%+/219%, and 0.76%+/20.96%, respectively (n=14,
mean +/2 SD).
In vitro culture of VSEL cells
The ability to expand and/or differentiate in vitro under
appropriate culture conditions is a common property of stem and
progenitor cells of different origins and has been reported for
murine VSEL cells. We entered hUCB derived VSEL cells into a
range of different culture media used to expand adult or
pluripotent stem and progenitor cells. These included stroma
supported culture (MEF, OP9), stroma-free culture in our own
media supplied with a range of different cytokines (SCF, TPO, FL,
LIF, EGF, FGF, TGF-beta) or small molecules (CHIR99021) and
commercial media prepared specifically to support hematopoietic,
mesenchymal or pluripotent stem cells (Methocult, Stempro MSC
SFM, Nutristem, TeSR1, ESGRO, MesenchymStem).
None of the media tested supported VSEL cell proliferation in
vitro. A low frequency of hematopoietic colonies were detected as
cobblestone areas giving rise to non adherent mature hematopoi-
etic cells on OP9 stroma. However, since such colonies arose at a
.100 fold higher frequency from the CD34
+CD45
dim population,
the few colonies originating from the neighbouring CD45
2VSEL
population are very likely to be due to carry over of a low
frequency of haematopoietic progenitor cells.
Figure 1. Gating of VSEL cells and CD34+CD45dim cells in hUCB. hUCB TNC were isolated by NH4Cl lysis and stained with fluorescent
antibodies, Hoechst 33342, and PI. A) Gating of living (PI
2) nucleated (Hoechst 33342
+) cells; B) pulse processing: exclusion of doublets (Hoechst-
W
high) and granulocytes (SSC-A
high). C) Gating of CD34
+CD45
dim Hoechst 33342
+PI
2. D) Gating of CD45
2Lin
2 cells. E) Gating of CD45
2Lin
2
CXCR4
+Hoechst 33342
+PI
2 VSEL cells. F) Expression of CD133 in CD34
+CD45
dim cells (blue) and VSEL cells (black).
doi:10.1371/journal.pone.0034899.g001
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Transcriptional profiling of purified VSEL cells was performed
by Affymetrix microarray analysis. For this study, we chose three
individual blood samples with prominent CD34
+VSEL cells and
included both CD45
2Lin
2CXCR4
+CD34
2 (CD34
2VSEL) and
CD45
2Lin
2CXCR4
+CD34
+ (CD34
+VSEL) cells separately in the
analysis. The mRNA profile revealed a high degree of similarity
between the CD34
2 and CD34
+VSEL populations, with no
indication of one population being more immature than the other.
However, we found close accordance between the surface antigens
measured by FACS analysis and the transcription level of their
corresponding genes measured by microarray (Table 1). The only
deviation was the level of CD34 mRNA in CD34
+VSEL cells,
which was both above the median and higher than in
CD34
2VSEL cells, but below the set threshold (Figure S1).
We classified our data sets in respect to more than 200
published transcription data sets from the GEO database to
compare the transcriptional profile of VSEL cells to those of
previously characterised, well-defined populations of pluripotent
stem cells, adult stem cells and mature blood cell types (Table S2).
Figure 5 shows the results of three different approaches. Firstly, a
transcriptome-wide principal component analysis including over
12000 genes revealed VSEL cells to be clearly distinct both from
all of the known stem cell populations and from the mature
hematopoietic lineages tested (Figure 5 A+B). The PCA illustrates
a developmental hierarchy ranging from the most immature
pluripotent stem cells (lower left) to mature hematopoietic lineages
(upper right). Considering PC1 and PC2, the transcriptional
signature of VSEL cells appears closest to the hematopoietic
lineage. However, PC 3 illustrates that VSEL cells are dissimilar to
Figure 2. Immunophenotype of CD45-Lin-Hoechst 33342+PI- cells. hUCB cells were subjected to multiparameter FACS analysis, and gated
according to Figure 1 D (either Lin
2 or CD235a
2). Among 22 markers tested, three were found positive on CD45
2Lin
2 cells: CXCR4, CD31 and CD84.
However, in contrast to previous reports, CD45
2Lin
2 cells contain very low amounts of either CD34
+ (1,2%+/20,6%; n=5) or CD133
+ (1,8%+/22,3%;
n=5) cells (B middle & right). A) Representative single analysis of markers on CD45
2Lin
2 cells. B+C) Representative replicate analysis of the
expression of CXCR4, CD34 and CD133 on CD45
2Lin
2 cells and on CD34
+CD45
dimcells.
doi:10.1371/journal.pone.0034899.g002
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similarity was observed to any of the mature tissue samples
included, and VSEL cells were clearly far removed from
pluripotent stem cells. A similar result was obtained by
hierarchical clustering (HCL) as shown in Figure 5 C. The un-
rooted tree diagram thus derived shows two main branches:
hematopoietic cells, and non-hematopoietic cells and tissues
including adult and pluripotent stem cells. VSEL cells locate as
a third, independent branch remote from all other cell types.
Finally, we focused on the transcription of 371 selected
pluripotency associated genes to investigate more directly the
relationship between VSEL and pluripotent stem cells. Figure 5
D shows that the transcriptional profile of these genes is highly
similar in embryonic stem cells (ESC) and induced pluripotent
stem cells (iPS). Furthermore, neuronal stem cells (NSC),
mesenchymal stromal cells (MSC), mature B-cells and VSEL cells
are clearly distinct from pluripotent stem cells, VSEL cells and B-
cells being most dissimilar and remote to ESC. Oct4, Nanog and
Sox2 were highest in iPS and ES cells with an expectedly high
level of Sox2 transcripts also in NSCs (Figure 5 E). In summary,
the transcriptional analysis confirm the absence of stemness
markers in VSEL cells, but reveal a unique transcriptional
signature with little similarities to other stem cell or mature blood
cell types.
VSEL cells show an aberrant karyotype and possess
hardly any cytoplasm
Our ficoll density gradient experiments and FACS analysis data
confirmed a relatively high density and small size of VSEL cells
compared to CD34
+CD45
dim cells (Figure 1). Furthermore,
direct measurement of FACS sorted CD45
2Lin
2CXCR4
+ VSEL
and CD34
+CD45
dim cells showed them to have diameters of
7.1 mm vs. 9.0 mm repectively (p,0.0001; Figure 6 B), which is
in close agreement with the size of CD45
2Lin
2CXCR4
+ cells
(7.4 mm) measured by ImageStream analysis by Zuba-Surma et al.
[15]. Surprisingly, despite this smaller size, a semi-quantitative
estimation of the DNA content using the cell permeable dye
Hoechst 33342 showed an approximately 2-fold higher fluores-
cence of VSEL cells compared to mononuclear CD34
+CD45
dim
cells. This suggested either binuclearity, tetraploidy, or an unusual
chromatin conformation that results in a significantly higher
intercalation of Hoechst into the DNA of VSEL cells (Figure 6 A).
Table 1. Immunophenotyping and transcriptional profiling of Lin-CD45- and VSEL cells.
Marker Synonyms
Typically present in tissue
or stem cell Present in Lin-CD45- cells and subpopulations Ref.
total
#) CXCR4
+CD34
2*) CXCR4
+CD34
+*)
MSCA-1 TNAP MSC 22 2 [13]
SSEA-3 ESC 2 n/a n/a [34]
SSEA-4 ESC; MSC; erythrocytes 2 n/a n/a [34–36]
Tra-1-81 PODXL ESC 22 2 [34]
CD15 SSEA-1; FUT4 murine ESC; granulocytes;
monocytes
22 2 [34,37]
CD31 PECAM-1 EPC; mature and primitive
hematopoietic cells
++ + [38–40]
CD34 HSPC; EPC 22 2 [41,42]
CD38 leukocytes; -ve on primitive
human HSPC
22 2 [43]
CD48 SLAMF2 lymphocytes; -ve on murine
HSPC
22 2 [44]
CD56(PSA) PSA-NCAM NSC 22 2 [45]
CD84 SLAMF5 most mature and primitive
hematopoietic cells
++ + [46]
CD90 Thy-1 HSPC 22 2 [47]
CD105 endoglin; SH-2 HSPC; MSC 22 2 [48,49]
CD133 prominin-1 HSPC; NSC; EPC; 22 2 [50–52]
CD140a PDGF-Ra murine MSC 22 2 [33]
CD144 VE-cadherin EPC 22 2 [38]
CD184 CXCR4; fusin most mature and primitive
hematopoietic cells
++ + [8,53]
CD243 MDR-1; p-gp reported in SP cells; blood-
brain barrier
22 2 [54]
CD244 SLAMF4 NK-cells; -ve on murine HSPC 22 2 [44]
CD271 p75(NTR) MSC; NSC 22 2 [13,55]
CD324 E-cadherin ESC; various tissues 22 2 [56]
CD338 ABCG2; BCRP-1 reported in SP cells; placenta 22 2 [57,58]
#)surface antigen expression measured by FACS analysis;
*)mRNA expression level measured by microarray analysis.
doi:10.1371/journal.pone.0034899.t001
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34899To investigate this further, we directly analysed highly purified
VSEL cells in cytospin preparations. Figure 6 C highlights the
clear morphological differences between VSEL cells and
CD34
+CD45
dim cells. Compared to CD34
+CD45
dim cells, VSEL
cells are not only smaller, but appear to possess barely any
cytoplasm and a less structured nucleoplasm, consistent with the
previous description by Kucia et al. [8]. In order to clarify the
ploidy status with respect to the higher Hoechst 33342
fluorescence, we used four different locus specific interphase FISH
probes for chromosomes 7, 8, 13 and 17. To our surprise, we
found that the majority of VSEL cells displayed an aberrant
karyotype, even with this limited number of markers. While
CD34
+CD45
dim cells generally displayed the expected diploid
karyotype with two signals from each of the probes used, VSEL
cells showed substantial deviations from the normal, ranging from
0–4 signals per probe and cell (Figure 6 D, E). Thus, the high
Hoechst 33342 fluorescence in VSEL cells results not from a
tetraploid, but from an aberrant karyotype.
Discussion
Very small embryonic like stem cells were isolated firstly from
murine bone marrow and later from human umbilical cord blood
as a rare population of small CD45
2Lin
2CXCR4
+ cells with a
high nucleus to cytoplasm ratio [8,9]. Our independent charac-
terization of CD45
2Lin
2CXCR4
+ VSEL cells from hUCB
confirms that they are indeed significantly smaller than
CD34
+CD45
dim hematopoietic cells, possess hardly any cytoplasm
and express both CD31 and CD84, but calls into question their
stem cell-like nature.
The identification and isolation of VSEL via FACS techniques
proved to be reliable and reproducible only after the adoption of a
number of measures to reduce non-specific signals, including the
exclusion of debris and dead cells on the basis of Hoechst 33342
and PI staining. The resulting populations were almost uniformly
positive for CXCR4, CD31 and CD84, but contained low to
undetectable amounts of CD133, CD34 and most adult and
embryonic stem cell markers. This pattern of surface antigen
expression was supported by transcriptional profiling of the highly
purified VSEL population, but contrasts with previous reports that
CD34 antigen is detectable on a higher frequency of VSEL cells
than is CXCR4 [8].
The transcriptional profiling also permitted comparison of
VSEL cells to published data covering a range of primitive and
mature blood cell types as well as a panel of adult and pluripotent
stem cells. This showed VSEL cells to be unique population with
no clear relation to either hematopoietic cells or other stem cell
types. These findings, together with the failure of hUCB VSEL to
respond to any of a range of culture environments designed to
Figure 3. Separation of CD34+CD45dim cells and VSEL cells by
ficoll density gradient centrifugation. Cells recovered from
interphase and pellet were lysed with NH4Cl and analyzed for the
frequency of CD34
+CD45
dim cells and CD45
2Lin
2CXCR4
+ VSEL cells,
respectively. A) Recovery of TNC in interphase and pellet (n=15). B)
Recovery of CD34
+CD45
dim cells and VSEL cells in the interphase
(n=15). C) Frequency of CD34
+CD45
dim cells and VSEL cells in
interphase and pellet, respectively (n=15).
doi:10.1371/journal.pone.0034899.g003
Figure 4. FACS sorting of VSEL cells from Lin2 hUCB cells derived from MACS lineage depletion of TNC. A+B) Two extreme UCB
samples with many (A) and very few (B) CD34
+VSEL cells, respectively. C) Frequency of CD34
+CD45
dim cells (upper middle gate in A+B), CD34
2VSEL
(CD45
2Lin
2CXCR4
+CD34
2, lower left gate in A+B), and CD34
+VSEL (CD45
2Lin
2CXCR4
+CD34
+, upper left gate in A+B) cells within PI
2 lymphocytes
(n=14).
doi:10.1371/journal.pone.0034899.g004
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34899Figure 5. Microarray analysis of sorted hUCB VSEL cells and comparison to other stem and mature cell types (listed in Table S2).
A+B) A genome-wide unbiased principal component analysis including 12621 genes classifies VSEL cells as remote to both pluripotent and adult
stem cell populations as well as mature blood cell lineages. C) Hierarchical clustering represented by an un-rooted tree diagram confirms the results
of the PCA. D) A heatmap comparison of 371 selected pluripotency associated genes shows substantial differences between VSEL cells and
pluripotent stem cells, but a high degree of similarity between ES and iPS cells. E) Normalized transcription level of the core pluripotency genes Oct4
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34899support the expansion of pluripotent or adult stem cells, call into
question any stem cell like character of the cells. Perhaps most
strikingly, we subsequently discovered that VSEL cells are clearly
aneuploid, so that using just four different probes identifies
karyotypic aberrations in the majority of cells, including the
complete absence of single loci.
The cumulative evidence therefore suggests strongly that hUCB
VSEL cells are the products of a defective or uncoordinated cell
division, leaving them with extensive karyotypic abnormalities.
The associated very low cytoplasmic volume would also be
consistent with the observed loss of cellular function. Although
aneuploidy has long been associated with cancer, it has recently
been observed in cultured pluripotent and neuronal stem cells as
well as normal neuronal progenitors and primary cells from
blastocysts, so that the tendency to generate aneuploid cells may
be a normal feature of regenerative systems [25–28]. Even so, the
aneuploid products themselves are unlikely to make a long term
contribution to regeneration, so that the sum of the evidence
presented here argues clearly against a stem cell identity of VSEL
cells from hUCB.
It has previously been reported that UCB derived VSEL cells
can be expanded to short term repopulating hematopoietic cells on
OP9 feeder layers [29]. However, we have shown in this study that
stringent separation of CD45
2 VSEL cells from the CD45
dim
hematopoietic progenitor and stem cell population by FACS
sorting is very difficult. For this reason, we suspect that the low
frequency of hematopoietic cells that we detected on OP9 stroma
seeded with the CD45- VSEL population result from carry-over of
(POU5F1), Nanog and Sox2 as part of D. Note that the Affymetrix microarray probes for POU5F1 do not comply with up to date quality standards as
they are known to detect pseudogenes.
doi:10.1371/journal.pone.0034899.g005
Figure 6. Cytometric and karyotypic analysis of CD34+CD45dim cells and VSEL cells. A) Comparison of the median Hoechst 33342
fluorescence, FSC-H and SSC-H of CD34
+CD45
dim cells and VSEL cells, respectively (n=15); B) Cell diameter of freshly FACS sorted CD34
+CD45
dim cells
and VSEL cells (n$110; p,0.001); C) May-Gru ¨nwald/Giemsa stained cytospin preparations of CD34
+CD45
dim cells (top) and VSEL cells (bottom). D–E)
Karyotypic analysis of cytospin preparations of CD34
+CD45
dim cells (top) and VSEL cells (bottom) stained with probes against D) centromere 7 (red)
and centromere 8 (green), and E) p53 (red) and DLeu (green). scales=10 mm.
doi:10.1371/journal.pone.0034899.g006
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hematopoietic differentiation of VSEL cells. Indeed, there has
been no independent evidence to date to support that a pure UCB
VSEL population possesses functional hallmarks of stem cells, such
as in vitro differentiation potential, high proliferative capacity or
the ability to self-renew in vivo. It is therefore questionable
whether UCB VSEL cells should be termed ‘‘stem cells’’ at all.
The properties of UCB VSEL cells reported here differ
markedly from those of VSEL cells derived from murine bone
marrow, which have been described similarly as putatively
pluripotent, small and rare CD45
2Lin
2Sca-1
+ cells. While
rigorous proof of pluripotency is also lacking for murine VSEL
cells, they have at least demonstrated functional adult stem cell
properties in vitro [9,30] and recent in vivo studies have shown
that murine VSEL cells can form bone tissue and may contribute
to heart regeneration [31,32]. Furthermore, Morikawa et al. have
identified a novel type of mesenchymal precursor (CD45
2Lin
2-
Sca-1
+PDGFR-a
+ ‘‘PaS’’ cells) within the VSEL cell population,
capable of engrafting in vivo and regenerating mesenchymal tissue
in the bone marrow [33]. There is therefore little doubt that the
VSEL cells isolated from murine bone marrow, while being
functionally heterogenous, contain very promising stem cell
activities. It is to be hoped that similar cells are present in human
tissues. However, our studies suggest strongly that the hUCB-
derived cells described to date as VSEL cells are not the human
equivalent of murine VSEL cells and should not be regarded as a
stem cell population.
Supporting Information
Figure S1 Transcript level of genes coding for selected surface
antigens in CD34
2VSEL and CD34
+VSEL cells. Genes with a
median transcript level above the threshold (3
rd quartile +1.56
inter quartile range (IQR)) were defined as positive, others as
negative. While most transcripts are negative, CD31, CD84 and
CD184 (CXCR4) are positive in both cell populations. These data
agree with the flow cytometric immunophenotyping of VSEL cells.
The level of CD34 mRNA in CD34
+VSEL cells was below the set
threshold, but was both the highest of all negative values and
higher than in CD34
2VSEL cell.
(TIF)
Table S1 Median transcription level of 371 selected pluripoten-
cy associated genes queried from www.genecards.org.
(DOC)
Table S2 Transcription data sets used in the microarray
analysis.
(DOC)
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